395P Interim analysis (IA) of the giredestrant (G) + ipatasertib (IPAT) arm in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC)
| Autor: | Jung, K.H. 1, Luen, S.J. 2, Oliveira, M. 3, Sohn, J. 4, Im, S-A. 5, Wander, S. 6, Hurvitz, S.A. 7, Sonnenblick, A. 8, Breton, V. 9, Collier, A. 10, Deb, S. 11, Ngo, H. 12, Schwab, R. 13, Shemesh, C. 14, Zhu, J. 13, Melia, C. Hernando 15 |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S347-S347 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|